Shanxi Huayuan Pharmaceutical Biotechnology

Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. is a pharmaceutical manufacturing company headquartered in Shuozhou, Shanxi Province, China. Established in 2011, the company focuses on the research, development, and production of a broad range of pharmaceutical products, including chemical drugs and traditional Chinese medicine (TCM). Its commercial portfolio features key cardiovascular treatments such as Telmisartan, Amlodipine, and Gemfibrozil, alongside antibiotics like Erythromycin. The company also produces specialized TCM formulations, including YiQing Granules and Bone and Tendon Tablets, targeting inflammation and musculoskeletal health. Operating from the Shuozhou Huairen County High-tech Industrial Park, the firm maintains robust manufacturing capabilities for solid dosage forms and active pharmaceutical ingredients (APIs). Shanxi Huayuan Pharmaceutical Biotechnology is committed to providing high-quality healthcare solutions and essential medications to the Chinese market.